Scientists discover potential new targets for Alzheimer’s drugs
Pathways involved in DNA repair and other cellular functions could contribute to the development of Alzheimer’s.
Pathways involved in DNA repair and other cellular functions could contribute to the development of Alzheimer’s.
Trained with a joint understanding of protein and cell behavior, the model could help with diagnosing disease and developing new drugs.
MIT engineers designed polymer microparticles that can deliver vaccines at predetermined times after injection.
Their study yielded hundreds of “cryptic” peptides that are found only on pancreatic tumor cells and could be targeted by vaccines or engineered T cells.
MIT chemists found a way to identify a complex sugar molecule in the cell walls of Mycobacterium tuberculosis, the world’s deadliest pathogen.
Informal help is a huge share of elder care in the U.S., a burden that is only set to expand. A new book explores different countries’ solutions.
During the early teen years, many new strains of C. acnes colonize the skin on our faces. This could be an optimal time for probiotic treatment.
The circuits could help researchers develop new treatments for fragile X syndrome and other diseases caused by mutations of a single gene.
MIT biologists have found that defects in some transfer RNA molecules can lead to the formation of these common conditions.
New research on a cytokine called IL-17 adds to growing evidence that immune molecules can influence behavior during illness.
At the 2025 MIT Energy Conference, energy leaders from around the world discussed how to make green technologies competitive with fossil fuels.
A new study finds natural and invented languages elicit similar responses in the brain’s language-processing network.
A new, highly efficient process for performing this conversion could make it easier to develop therapies for spinal cord injuries or diseases like ALS.
The findings provide new drug targets for stopping the infection’s spread.
The nanoparticle-based vaccine shows promise against many variants of SARS-CoV-2, as well as related sarbecoviruses that could jump to humans.